NCT03711708View on ClinicalTrials.gov

Relative Bioavailability Study of Zoloft Oral Solution to Zoloft Tablets

PHASE4CompletedINTERVENTIONAL
Enrollment

36

Participants

Timeline

Start Date

November 6, 2018

Primary Completion Date

February 27, 2019

Study Completion Date

February 27, 2019

Conditions
Healthy
Interventions
DRUG

Zoloft Oral Solution

Test Product: 50 mg sertraline administered as 2.5 mL of Zoloft Oral Solution (20 mg/mL) after dilution with 120 mL of water

DRUG

Zoloft tablets

Reference Product: 50 mg sertraline administered as 1x Zoloft 50 mg tablet

Trial Locations (1)

74935-530

ICF - Instituto de Ciencias Farmaceuticas de Estudos e Pesquisas Ltda, Aparecida de Goiânia

All Listed Sponsors
lead

Pfizer's Upjohn has merged with Mylan to form Viatris Inc.

INDUSTRY

NCT03711708 - Relative Bioavailability Study of Zoloft Oral Solution to Zoloft Tablets | Biotech Hunter | Biotech Hunter